What happened
Original notice title
Public Health Alert Concerning Nopalina Flax Seed Powder and Nopalina Flax Seed Capsules and Salmonella Contamination
From the archived source record
Information on Select Dietary Supplement Ingredients and Other Substances Salud Natural Entrepreneur, Inc. issued a press release on January 28, 2020 notifying the public of a voluntary recall for certain lots of Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsule) products due to possible Salmonella contamination. The FDA is advising consumers to stop using Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsules) identified by the lot numbers above due to possible Salmonella contamination. Consumers of these products who are experiencing symptoms of salmonellosis should contact their health care provider. To date, there are no reports of illnesses associated with the products. Salmonella are a group of bacteria that can cause gastrointestinal illness and fever called salmonellosis. Most people infected with Salmonella begin developing symptoms 12 to 72 hours after infection. The illness usually lasts four to seven days and most people recover without treatment. The FDA collected a product sample of senna leaves powder, an ingredient used to manufacture the Nopalina Flax Seed Fiber (powder) and Nopalina Flax Seed Fiber (capsules), that tested positive for three types of Salmonella including Salmonella Gaminara, Salmonella Kentucky, and Salmonella Oranienburg. The FDA notified the firm of the results. To date, we are not aware of illnesses linked to these products. The FDA intends to use all available tools to remove contaminated product from the market. La FDA recomienda a los consumidores que dejen de usar la fibra de semilla de lino Nopalina (en polvo) y la fibra de semilla de lino Nopalina (en cápsulas) identificadas por los números de lote anteriores debido a la posible contaminación de Salmonella . Las personas que hayan consumido estos productos y que experimentan síntomas de salmonelosis deben comunicarse con su proveedor de atención médica. Hasta la fecha, no hay reportes de enfermedades asociadas con los productos.
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- Published FDA communication
- Source checked
- Jul 16, 2026
- Record revision
- 74d7cbdbb7ba
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →